Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
Clinical trial NCT06523621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06523621
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-03-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.